*  Oraltag Dosage Guide - Drugs.com
Body Imaging iohexol, Omnipaque 300, ioversol, Omnipaque 350, Optiray 300, Optiray 320, Omnipaque 240, Omnipaque 180, Omnipaque ... iohexol). Includes dose adjustments, warnings and precautions. ... More about Oraltag (iohexol). *Side Effects. *During Pregnancy ...
  https://www.drugs.com/dosage/oraltag.html
*  OMNIPAQUE 300 (Iohexol) dosage, indication, interactions, side effects | EMPR
Iohexol) drug information & product resources from MPR including dosage information, educational materials, & patient ... Iohexol 647mg (equivalent to 300mg of organic iodine) per mL; soln; preservative-free. ...
  http://www.psychiatryadvisor.com/omnipaque-300/drug/3977/
*  A Phase 1, Open Label, Placebo-Controlled Study to Evaluate the Effect of GSK1349572 on Iohexol and Para-Aminohippurate...
Subjects will also receive iohexol and PAH infusions on Days -1, 7 and 14. There will be a follow-up visit 7-10 days after the ... Subjects will also receive iohexol and PAH infusions on Days -1, 7 and 14. There will be a follow-up visit 7-10 days after the ... Subjects will also receive iohexol and PAH infusions on Days -1, 7 and 14. There will be a follow-up visit 7-10 days after the ... Glomerular Filtration Rate (GFR) as measured by iohexol plasma clearance at days -1, 7 and 14 [ Time Frame: 14 days ] ...
  https://clinicaltrials.gov/ct2/show/record/NCT01214993?view=results
*  Omnipaque 140 / iohexol NDA 018956 international drug patent coverage, generic alternatives and suppliers
iohexol. SOLUTION;URETHRAL. 018956-007. Jun 1, 1994. ► Subscribe. ► Subscribe. Ge Healthcare. OMNIPAQUE 180. iohexol. SOLUTION; ... iohexol. SOLUTION;INJECTION, ORAL. 018956-004. Dec 26, 1985. ► Subscribe. ► Subscribe. Ge Healthcare. OMNIPAQUE 350. iohexol. ... iohexol. INJECTABLE;INJECTION. 018956-005. Nov 30, 1988. ► Subscribe. ► Subscribe. Ge Healthcare. OMNIPAQUE 180. iohexol. ... iohexol. INJECTABLE;INJECTION. 018956. NDA. GE Healthcare Inc.. 0407-1411. 0407-1411-10. 10 VIAL, GLASS in 1 BOX (0407-1411-10 ...
  https://www.drugpatentwatch.com/p/NDA/018956
*  A Pilot Safety and Pharmacokinetic Study of MB-102 Versus Iohexol and the Use of the Non-invasive Optical Renal Function...
... and pharmacokinetic study of MB-102 versus iohexol and the use of the non-invasive optical renal function monitor (ORFM) device ... A Pilot Safety and Pharmacokinetic Study of MB-102 Versus Iohexol and the Use of the Non-invasive Optical Renal Function ... A Pilot Safety and Pharmacokinetic Study of MB-102 Versus Iohexol and the Use of the Non-invasive Optical Renal Function ...
  http://adisinsight.springer.com/trials/700277185?error=cookies_not_supported&code=2c88a46c-8ed9-4f15-a9a0-e677e20298f4
*  The iodinated radiographic contrast medium iohexol mimics the vasodilator effect seen with small increases in extracellular K+...
The IRCM iohexol and KCl, injected as boluses into perfused PE-constricted rabbit ear arteries, caused transient decreases in ... Iohexol- and K + -induced pressure decreases were significantly reduced in the presence of 10M ouabain alone or in combination ... Neither iohexol- nor K + -induced pressure decrease was significantly changed in the presence of barium alone compared to ... The iodinated radiographic contrast medium iohexol mimics the vasodilator effect seen with small increases in extracellular K+ ...
  http://liu.diva-portal.org/smash/record.jsf?pid=diva2:271039
*  Development of a capillary electrophoretic method for determination of plasma clearance of iohexol in dogs and cats
It has been proposed that iohexol is the most accurate marker for GFR determination in cats and dogs. However, there is a need ... Development of a capillary electrophoretic method for determination of plasma clearance of iohexol in dogs and cats. Hellqvist ... iohexol; iopromide; glomerular filtration rate; Omnipaque®; bioanalytical method validation National Category Pharmaceutical ... a validated capillary electrophoretic method that covers the concentration range for a full curve clearance estimate of iohexol ...
  http://uu.diva-portal.org/smash/record.jsf?pid=diva2:799128
*  A Phase 1, Open Label, Placebo-Controlled Study to Evaluate the Effect of GSK1349572 on Iohexol and Para-Aminohippurate...
Subjects will also receive iohexol and PAH infusions on Days -1, 7 and 14. There will be a follow-up visit 7-10 days after the ... Subjects will also receive iohexol and PAH infusions on Days -1, 7 and 14. There will be a follow-up visit 7-10 days after the ... Subjects will also receive iohexol and PAH infusions on Days -1, 7 and 14. There will be a follow-up visit 7-10 days after the ... Drug Information available for: Iohexol Dolutegravir Dolutegravir sodium Genetic and Rare Diseases Information Center resources ...
  https://clinicaltrials.gov/show/NCT01214993?order=144
*  The Effects of Iohexol Administration on Technetium Thyroid Scintigraphy in Normal Cats | Advanced Veterinary Medical Imaging
The Effects of Iohexol Administration on Technetium Thyroid Scintigraphy in Normal Cats. by Michael R. Broome, DVM, MS, Dipl. ... After iohexol administration, mean T:S was significantly decreased below baseline only on day 1. At no point during the study ... due to iohexol administration. Routine thyroid scintigraphy was performed in eight cats by intravenous (IV) injection of 185 ... MBq (5 mCi) of 99mTcO4- both 4 days before and 0, 1, 3, 7, 14, and 28 days after IV administration of 880 mg I/kg iohexol (240 ...
  https://avmi.net/information/hyperthyroid-hints/the-effects-of-iohexol-administration-on-technetium-thyroid-scintigraphy-in-normal-cats/
*  Intravascular studies with iohexol (Omnip... & related info | Mendeley
In order to assess the vascular clinical trial program of iohexol (Omnipaque) in Europe, the results from the first 49 vascular ... Intravascular studies with iohexol (Omnipaque). Results from the first 49 clinical trials.. *Andrew E ... The overall tolerability of iohexol was superior to that of monomeric ionic media and seemed to be as good as that of ... In order to assess the vascular clinical trial program of iohexol (Omnipaque) in Europe, the results from the first 49 vascular ...
  https://www.mendeley.com/research-papers/intravascular-studies-iohexol-omnipaque-results-first-49-clinical-trials/
*  ASYSTOLE ASSOCIATED WITH IOHEXOL MYELOGRAPHY IN A DOG - Carroll - 1997 - Veterinary Radiology & Ultrasound - Wiley Online...
ASYSTOLE ASSOCIATED WITH IOHEXOL MYELOGRAPHY IN A DOG. Authors. *. Gwendolyn L. Carroll MS, DVM,. Corresponding author. * ... BJ Leitch, AC Hartman, IG Mayhew, BR Jones, AJ Worth, Permanent monoparesis in a dog after intramedullary injection of iohexol ... Incidence of and risk factors for seizures after myelography performed with iohexol in dogs: 503 cases (2002-2004), Journal of ... Risk factors associated with development of seizures after use of iohexol for myelography in dogs: 182 cases (1998), Journal of ...
  http://onlinelibrary.wiley.com/doi/10.1111/j.1740-8261.1997.tb00857.x/abstract
*  Two-Point Measurement of Glomerular Filtration Rate by Iohexol Plasma Disappearance - Full Text View - ClinicalTrials.gov
Iohexol GFR Drug: Iohexol Iohexol, a non-ionic, low osmolar, X-ray contrast medium (OmnipaqueR) that is safe and non-toxic and ... blood sample for iohexol level, serum creatinine, cystatin C, and hematocrit at baseline, prior to iohexol infusion, 2 hours ... Extrarenal elimination of iohexol in a setting of reduced GFR is negligible[16]. Iohexol is measured in deproteinized plasma or ... Study subject will receive 5 ml of iohexol solution (Omnipaque 300, corresponding to 647 mg iohexol per ml or 300 mg iodine per ...
  https://clinicaltrials.gov/ct2/show/NCT01545531
*  Iohexol - Wikipedia
Iohexol is an iodinated non-ionic radiocontrast agent. It is in the low osmolar family. Iohexol was approved for medical use in ... "Iohexol". International Drug Price Indicator Guide. Retrieved 8 December 2016. GE Healthcare (May 2006). "Omnipaque (Iohexol) ... The osmolality of iohexol ranges from 322 mOsm/kg-approximately 1.1 times that of blood plasma-to 844 mOsm/kg, almost three ... Iohexol, sold under the trade names Omnipaque among others, is a contrast agent used during X-rays. This includes when ...
  https://en.wikipedia.org/wiki/Iohexol
*  Oraltag / iohexol NDA 205383 global drug patent coverage, generic alternatives and suppliers
iohexol. FOR SOLUTION;ORAL. 205383. NDA. Interpharma Praha, a.s.. 54702-501. N. 54702-501-62. ... iohexol. FOR SOLUTION;ORAL. 205383. NDA. Interpharma Praha, a.s.. 54702-501. N. 54702-501-98. ... The generic ingredient in ORALTAG is iohexol. There are three drug master file entries for this compound. Three suppliers are ...
  https://www.drugpatentwatch.com/p/NDA/205383
*  Extrarenal plasma clearance of iohexol and other markers of normal and reduced glomerular filtration rate
... Almén, Torsten LU ; ... Extrarenal plasma clearance of iohexol and other markers of normal and reduced glomerular filtration rate}, url = {http://dx. ...
  https://lup.lub.lu.se/search/publication/1111161
*  Comparison of Plasma Clearance of Exogenous Creatinine, Exo-Iohexol, and Endo-Iohexol over a Range of Glomerular Filtration...
The study investigated plasma clearance of exogenous creatinine (PECCT), exo-iohexol ... Comparison of Plasma Clearance of Exogenous Creatinine, Exo-Iohexol, and Endo-Iohexol over a Range of Glomerular Filtration ... The study investigated plasma clearance of exogenous creatinine (PECCT), exo-iohexol (PexICT) and endo-iohexol (PenICT) in six ...
  https://avmi.net/information/hyperthyroid-hints/comparison-of-plasma-clearance-of-exogenous-creatinine-exo-iohexol-and-endo-iohexol-over-a-range-of-glomerular-filtration-rates-expected-in-cats/
*  Munin: The Renal Iohexol Clearance Survey Follow-Up Study
In the Renal Iohexol Clearance Survey in Tromsø 6 (RENIS-T6), we measured the GFR (mGFR) in 1627 middle-aged people without ...
  https://munin.uit.no/handle/10037/12838